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Drosophila p53 Binds a Damage Response Element
at the reaper Locus
1993; Cho et al., 1994), and a tetramerization domain
(Kraiss et al., 1988; Jeffrey et al., 1995) are all required
for p53 to activate expression of target genes. The p53
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Summary tor of this checkpoint (el-Deiry et al., 1993; Deng et al.,
1995). Although the target genes that regulate apoptosis
The tumor suppressor gene p53 regulates multiple cel- are less clear, important examples include fas/apo1 and
lular responses to DNA damage, but the transcrip- bax (Miyashita and Reed, 1995; Owen-Schaub et al.,
tional targets that specify these responses are incom- 1995; Munsch et al., 2000). In addition, transcription-
pletely understood. We describe a Drosophila p53 independent mechanisms can also contribute to the in-
homolog and demonstrate that it can activate tran- duction of apoptosis by p53 (Caelles et al., 1994). Al-
scription from a promoter containing binding sites for though many components of DNA damage checkpoint
human p53. Dominant-negative forms of Drosophila pathways have been described in yeast (Kitazono and
p53 inhibit both transactivation in cultured cells and Matsumoto, 1998; Weinert, 1998), no homologs of p53
radiation-induced apoptosis in developing tissues. have been identified in a genetically tractable model
The cis-regulatory region of the proapoptotic gene organism. The recent demonstration that human p53
reaper contains a radiation-inducible enhancer that expression can disrupt Drosophila eye development
includes a consensus p53 binding site. Drosophila p53 (Yamaguchi et al., 1999) suggests that studies in Dro-
can activate transcription from this site in yeast and sophila could help to identify conserved targets of p53.
a multimer of this site is sufficient for radiation induc- In Drosophila, as in vertebrates, apoptosis occurs as
tion in vivo. These results indicate that reaper is a an adaptive response to genotoxic stress. The Drosoph-
direct transcriptional target of Drosophila p53 follow- ila genes rpr, grim, and hid are potent activators of
ing DNA damage. caspase-dependent apoptosis (reviewed in Abrams,
1999; McCall and Steller, 1997) that map to a 300 kb
Introduction genomic interval required for all programmed cell death
in the embryo (White et al., 1994). Three observations
Eukaryotic cells exhibit a variety of responses to geno- indicate that a radiation-induced signaling pathway me-
toxic stress including cell cycle arrest, apoptosis, and diates apoptosis through transactivation of rpr: dele-
induction of DNA repair systems (Friedberg et al., 1995). tions removing rpr, grim, and hid block radiation-
In mammals, the tumor suppressor protein p53 is the induced apoptosis (White et al., 1994); rpr transcription
most widely studied regulator of cellular responses to is induced by ionizing radiation (Nordstrom et al., 1996);
DNA damage (reviewed in Ko and Prives, 1996; Levine, and rpr expression is sufficient to induce apoptosis (Hay
1997; May and May, 1999). Induction of p53 activity by et al., 1995; White et al., 1996). Together, these observa-
stimuli including DNA damage, hypoxia, and oncogene tions imply the existence of a radiation-induced signal-
activation is a critical mechanism in limiting cancer de- ing pathway that mediates apoptosis through transacti-
velopment, as indicated by the loss of p53 function or vation of rpr. Here we report the characterization of a
regulation in most human tumors. Activation of this tran- Drosophila p53 homolog and provide evidence that rpr
scription factor can either eliminate injured cells through is one of its direct transcriptional targets in vivo.
apoptosis or initiate reversible cell cycle arrest. Despite
the ongoing effort to understand p53 function, the mech-
Results and Discussionanisms by which this protein specifies these distinct
adaptive options remain unclear.
A Drosophila Homolog of p53Transcriptional regulation appears to be the primary
We used TBLASTN to search the high-throughput geno-function of p53 (Ko and Prives, 1996; Levine, 1997; May
mic sequence (HTGS) database for sequences similarand May, 1999). An acidic transcriptional activation do-
to p53. A region of working draft sequence from BACmain (Fields and Jang, 1990; Unger et al., 1992), a se-
clone R17P04 (cytological region 94D, GenBank acces-quence-specific DNA-binding domain (Pavletich et al.,
sion number AC008200) was predicted to encode a pep-
tide with similarity to the DNA-binding domain of p53.³ To whom correspondence should be addressed (e-mail: gerry@
Comparison of this sequence with the database of Dro-fruitfly.berkeley.edu [G. M. R.], abrams@utsw.swmed.edu [J. M. A.]).
§ These authors contributed equally to this work. sophila EST sequences (Berkeley Drosophila Genome
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Project/HHMI EST Project, http://www.fruitfly.org) re- contains a basic region (9/26 amino acids) that helps
regulate sequence-specific DNA binding by p53 and canvealed ten overlapping cDNA clones, seven derived from
an embryonic cDNA library and three from an adult head itself bind either DNA or RNA (reviewed in Levine, 1997).
Although Dmp53 has little sequence similarity with Hp53library. We sequenced two 1.5 kilobase cDNAs, LD35041
(GenBank accession number AF224713) from the em- in this region, it is enriched in basic residues (6/24).
Adjacent to the basic region of Hp53 is a small domainbryonic library and GH11591 (GenBank accession num-
ber AF224714) from the head library. The cDNAs are required for tetramerization. The primary sequence in
this region is poorly conserved in Dmp53, althoughidentical except that the head cDNA has an additional
7 nucleotides at the 59 end and an additional 48 nucleo- Gly334, a critical ªhingeº residue (Jeffrey et al., 1995) is
conserved in all species including Drosophila. A role fortides at the 39 end. Comparison of the cDNA sequence
to genomic sequence identified 8 exons spanning 3.8 this region in Dmp53 oligomerization is supported by
yeast two-hybrid experiments discussed below.kilobases (Figure 1A). We have designated this gene
p53 to reflect its similarity in sequence and function to Phosphorylation and acetylation have been impli-
cated in regulating Hp53 stability and transcriptionalmammalian p53 (see below). In this report, we use
Dmp53 and Hp53 to distinguish between the Drosophila activity following DNA damage (Lakin and Jackson,
1999). Sites of particular note are the Ser±Glu aminomelanogaster and human genes.
Comparison of the predicted Dmp53 protein with acid pairs at positions 15 and 37, which can be serine
phosphorylated by members of the ATM family of DNAHp53 indicated that residues critical for DNA binding,
as revealed in the three-dimensional structure of p53 damage-responsive kinases (Figure 1B). The nearby
Ser4±Glu5 pair in Dmp53 might be a target for one ofbound to DNA (Cho et al., 1994), are conserved in Dro-
sophila. In Figure 1B, the deduced 385 amino acid open these kinases. Among the acetylation sites that have
been described, Lys382 in Hp53 has a possible equiva-reading frame is shown aligned to human, zebrafish,
Xenopus, and squid p53 as well as human p73a. In lent at Lys373 in Dmp53 (Figure 1B). The conservation
of these potential regulatory sites in Dmp53 suggestshuman tumors, mutations that inactivate p53 function
are clustered in the well-conserved DNA-binding do- that some of the proteins that modulate p53 activity are
conserved between mammals and Drosophila.main (Cho et al., 1994; Hollstein et al., 1994; Soussi
and May, 1996). Among the six most frequent sites of Figure 1C provides an overview of the domains in
several p53 family members. As discussed above,mutation in tumors, four are identical in Dmp53 and the
other two are similar (Figure 1B). Two of the mutation Dmp53 contains the critical residues required for a se-
quence-specific DNA-binding domain, an N-terminalhotspots correspond to residues that directly contact
DNA. Among the remaining six DNA-binding amino acidic region, and a C-terminal basic region. Squid p53
and some splice forms of human p73 and p63 contain anacids, four of the residues are identical, one is similar,
and one is not conserved (Figure 1B). Finally, the four extended C-terminal tail that contains a putative sterile
alpha motif (SAM) domain (Thanos and Bowie, 1999),residues that bind zinc are also conserved in Dmp53
(Figure 1B). Thus, despite being the most divergent p53 believed to mediate protein±protein interactions. None
of our cDNAs for Dmp53 contain this C-terminal domainfamily member described to date, the conservation of
amino acid residues required for DNA binding suggests and are, in this respect, more similar to the mammalian
p53. Excluding the C-terminal tail, the sequence ofthat Dmp53 will interact with the consensus binding
sequence for Hp53. Dmp53 is equally distant from human p53, human p73,
and squid p53.The regions outside the DNA-binding domain of
Dmp53 show less obvious sequence similarities to Hp53
(Figures 1B and 1C). The N terminus of Dmp53 does not
appear to contain either an Mdm2-binding motif (Kussie DNA Binding and Oligomerization
by Drosophila p53et al., 1996) or a proline-rich region (Walker and Levine,
1996). However, the N termini of Dmp53 and Hp53 share To initially characterize Dmp53 function, we used yeast
one- and two-hybrid assays previously used to examinea high proportion of acidic residues. Thus, it is possible
that the function of this domain in transcriptional activa- the biochemical functions of Hp53 (Figure 2). For each
assay, five Dmp53 derivatives were tested: full-length,tion is conserved in Dmp53. The C terminus of Hp53
Figure 1. Molecular Characterization of Drosophila p53
(A) Diagram of Drosophila p53 gene structure. Boxes represent the eight exons comprising p53 as deduced from comparison of two cDNAs
(GenBank accession numbers AF224713 and AF224714) and genomic sequence from cytological region 94D. Open boxes indicate untranslated
regions and filled boxes indicate coding regions.
(B) Alignment of p53 homologs. Amino acid sequences from fly (Drosophila melanogaster) p53, human p53, frog (Xenopus laevis) p53, zebrafish
(Danio rerio) p53, human p73, and squid (Loligo forbesi) p53 were aligned using CLUSTAL-W. The extended C-terminal regions of human p73
and squid p53 are not shown. Amino acid residues shaded dark are identical and those shaded light are similar in at least three of the six
homologs. Human p53 domains associated with transcriptional activation (txn act), sequence-specific DNA binding, tetramerization (tet), and
basic amino acid residues (basic) are indicated with brackets. Five regions conserved in p53 family members (Soussi and May, 1996) are
indicated with roman numerals and a solid line. Human p53 amino acid residues that bind DNA (D) or Zinc (Z) are noted as are the six positions
that are most frequently mutated in human cancers (*). Selected sites of human p53 phosphorylation (P) and acetylation (Ac) are indicated.
A glycine that is required at a hinge position in the tetramerization domain is also marked (h).
(C) Schematic representation of p53 domains. Percent sequence identities (and similarities) are indicated for three regions of Drosophila and
human p53. An extended C-terminal tail containing a putative SAM (sterile alpha motif) is present in squid p53 and human p73a but not
Drosophila or human p53. Numbers above the alignments indicate amino acid positions in Drosophila p53.
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To test for oligomerization, we used a two-hybrid
assay (Iwabuchi et al., 1993) and the same reporters as
described for the activation assay. Dmp53(Nt) was not
tested with the lacZ reporter because it gave a weak
positive signal in the activation assay; all other Dmp53
derivatives were tested against themselves in the two-
hybrid assay since, tested alone, these fusions were
unable to activate the GAL4-dependent reporters. For
all three reporters, oligomerization activity was strong-Figure 2. Conserved Activities of Drosophila p53 in Yeast One- and
est with the Dmp53(Ct) fusions. Full-length Dmp53 andTwo-Hybrid Assays
Dmp53(259H) exhibited weaker oligomerization activityDmp53 derivatives used to create GAL4 fusions are shown schemat-
ically. For single domain derivatives, the amino acid residues in- in this assay. These results suggest that, despite the lack
cluded are as follows: Nt, 1±83; Db, 84±281; Ct, 282±385. DNA bind- of sequence similarity in the putative tetramerization
ing, transcriptional activation, and oligomerization assays were domain, the C-terminal region of Dmp53 does contain
performed as described in the text. For transcriptional activation sequences that can mediate oligomerization.
and oligomerization experiments, results are presented as b-galac-
tosidase activity in liquid culture/growth on selective media. For
each experiment, the relative b-galactosidase activity compared to Drosophila p53 Functions as a Transcriptional
an empty vector control is indicated as follows: 10- to 30-fold in- Activator in Cultured Cells
crease (11); 3- to 10-fold increase (1); less than 3-fold increase We tested the ability of wild-type and mutant forms of
(2). Growth on media lacking adenine and histidine is indicated as Dmp53 to activate transcription in Drosophila S2 cells.
follows: rapid growth (11), slow growth (1), or no growth (2). All
Two variants with point mutations in the DNA-bindingexperiments were done in triplicate. ND, not done.
domain were also used. As described above, Dmp53
(259H) contains a point mutation that directly disrupts
DNA binding. Dmp53(155H) contains a mutation equiva-Dmp53; N-terminal fragment, Dmp53(Nt); central DNA-
binding fragment, Dmp53(Db); C-terminal fragment, lent to the hotspot mutation 175H in Hp53; this residue
does not directly contact DNA and the mutation mayDmp53(Ct); and full-length with a point mutation in the
DNA-binding domain, Dmp53(259H). The 259H point disrupt p53 function by partially unfolding the DNA-bind-
ing domain (discussed in Cho et al., 1994). For eachmutation corresponds to the Hp53 mutational hotspot
at position 273. In Hp53, this amino acid directly con- transfection, we examined the localization of Dmp53
using polyclonal antibodies raised against the C termi-tacts DNA and is required for DNA binding (Cho et al.,
1994). nus of the protein (see Experimental Procedures). We
found that wild-type Dmp53 (Figures 3A and 3B) andTo assay for DNA binding (Luo et al., 1996), we fused
the activation domain of GAL4 to Dmp53 derivatives the two point mutant derivatives (not shown) were local-
ized to the nucleus of transfected cells. In contrast,and tested them in directed one-hybrid assays (Figure
2). Two reporter constructs were tested for each GAL4- Dmp53(Ct) was found in both the cytoplasm and the
nucleus (Figures 3C and 3D).Dmp53 hybrid: the negative control plasmid (pLacZi)
contains a minimal promoter upstream of the lacZ gene; We used two reporter constructs that originally estab-
lished the transcriptional activity of Hp53 (Kern et al.,the tester plasmid (p53BLUE) contains three copies of
a 20 bp consensus binding site for Hp53 upstream of 1992). One construct, PG13-CAT, contains a multimer of
an Hp53 binding site upstream of a chloramphenicolthe minimal promoter. Full-length Dmp53 was able to
activate transcription from the reporter containing Hp53 acetyl transferase (CAT) reporter gene. A second con-
struct, MG15-CAT, contains a multimer of a mutated sitebinding sites, but not from the negative control reporter.
None of the individual domains (Nt, Db, Ct) were able to that is not bound by Hp53. Transfection of these report-
ers into S2 cells does not cause increased CAT activityactivate transcription and importantly the 259H mutation
specifically eliminated activation. These results indicate relative to control cells (Figure 3E). Cotransfection of
PG13-CAT and a vector expressing Dmp53 results inthat Dmp53 can interact with a consensus binding site
for Hp53 and that a residue required for sequence spe- a 10-fold increase in CAT activity compared to cells
transfected with an empty expression vector. Cotrans-cific binding in Hp53 plays a similar role in Dmp53.
To test for transcriptional activation (Fields and Jang, fection of MG15-CAT and Dmp53 results in only a 2-fold
increase in CAT activity. Expression of either point mu-1990), we fused the DNA-binding domain of GAL4 to
Dmp53 derivatives. Three GAL4-dependent reporter tant or the C-terminal fragment does not increase activa-
tion of the PG13-CAT reporter over background levels.constructs were present: the lacZ gene under control
of the GAL7 promoter, the ADE2 gene under control of These results demonstrate that wild-type, but not mu-
tant, Dmp53 can activate transcription from a promoterthe GAL2 promoter, and the HIS3 gene under control of
the GAL1 promoter. While full-length Dmp53 was unable containing binding sites for human p53. Thus, the se-
quence conservation between Hp53 and Dmp53 reflectsto mediate detectable transcriptional activation of any
reporter, Dmp53(Nt) conferred modest transcriptional functional conservation of DNA binding and transcrip-
tional activation.activation of the lacZ reporter construct. However, this
derivative did not activate sufficient transcription from Most p53 mutants in human tumors can act as domi-
nant-negative forms (Kern et al., 1992), typically leavingthe ADE2 and HIS3 constructs to allow growth on plates
without adenine and histidine (not shown). The weak the tetramerization domain intact but disrupting DNA
binding. Such variants are thought to suppress activitytranscriptional activation due to the N terminus does not
provide a strong conclusion about its in vivo function. of the wild-type protein through the formation of inactive
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Figure 3. Transcriptional Activation by Wild-
Type and Mutant Drosophila p53
(A±D) Transfected S2 cells stained with anti-
bodies against Dmp53 (A and C) and DAPI to
visualize DNA (B and D). The fluorescent and
phase images of each cell are superimposed.
Cells were transfected with either wild-type
Dmp53 (A and B) or Dmp53(Ct) (C and D).
(E) Cells were transfected with wild-type
Dmp53 (wt), point mutants (155H, 259H), or
a C-terminal fragment (Ct) to test for tran-
scriptional activation from PG13 (PG), a pro-
moter containing wild-type binding sites for
Hp53, or MG15 (MG), a promoter containing
mutant binding sites.
(F) Cells were cotransfected with wild-type
Dmp53 (wt) and a 3-fold excess of transcrip-
tionally inactive forms of Dmp53. All transfec-
tions contain PG13.
A dash indicates that the empty starting vec-
tor pGUS was used to equalize the total
amount of DNA in each experiment (E and F).
Error bars indicate the SEM.
complexes. We tested whether the transcriptionally in- transgenic strains carrying the Dmp53(259H) point mu-
tant and the Dmp53(Ct) derivative. A similar C-terminalactive forms of Dmp53 could inhibit transcription medi-
ated by wild-type Dmp53 in S2 cells. Cotransfection of derivative has been used for tissue-specific inactivation
of p53 in mice (Bowman et al., 1996). The Dmp53 variantsa 3-fold excess of Dmp53(155H) reduced transcription
by wild-type Dmp53 by roughly 50% whereas cotrans- were specifically expressed in the posterior half of the
fection of either Dmp53(259H) or Dmp53(Ct) in similar developing Drosophila wing using an engrailed-GAL4
amounts reduced transcription by wild-type Dmp53 to driver line (Figures 4A±4C) and effects on damage-
near background levels (Figure 3F). Therefore, like their induced apoptosis and cell cycle arrest were monitored
human counterparts, these Dmp53 variants can act as after irradiation.
dominant-negative forms that partially or completely We compared the levels of apoptosis in untreated
block activity of the wild-type protein. The dominant- and irradiated wing discs expressing dominant-negative
negative activity of Dmp53(Ct) is consistent with the Dmp53. In untreated wild-type discs (Figure 4G), there
observation in yeast assays that this domain contains are a small number of clustered apoptotic cells as visual-
an oligomerization domain. ized by staining with the vital dye acridine orange. In
discs with engrailed-GAL4 driving expression of domi-
nant-negative Dmp53, there is no substantial differenceDominant-Negative Drosophila p53 Blocks
in the level of apoptosis in the anterior and posteriorRadiation-Induced Apoptosis
halves of the disc (Figures 4H and 4I). Following irradia-To perturb the function of Dmp53 during Drosophila
tion, there is a massive increase in the amount of apopto-development, we directed expression of dominant-neg-
sis throughout wild-type wing discs (Figure 4D). How-ative forms in vivo using the GAL4-UAS system (Brand
and Perrimon, 1993). For these studies, we produced ever, in animals expressing dominant-negative Dmp53
Cell
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Figure 4. Dominant-Negative Forms of Dro-
sophila p53 Block Radiation-Induced Apo-
ptosis
The wing pouch regions of third instar larval
wing discs are shown with anterior to the left.
All discs, including the wild-type control,
express GAL4 in the posterior compartment
under control of engrailed regulatory se-
quences. A dashed line indicates the approxi-
mate location of the anterior±posterior com-
partment boundary (A±F). No other transgene
is present in wild-type discs (A, D, G, J, and
M). The dominant-negative point mutant
Dmp53(259H) is present in en:259H discs and
is controlled by a GAL4-responsive promoter
(B, E, H, K, and N). The dominant-negative
C-terminal derivative Dmp53(Ct) is present in
en:Ct discs and is similarly controlled by a
GAL4-responsive promoter (B, E, H, K, and
N). The overall structure of a wild-type wing
disc is shown with the nuclear dye DAPI (A).
Staining with an antibody against Dmp53 (B
and C) reveals the engrailed-GAL4-depen-
dent expression of dominant-negative forms
of Dmp53. Staining with the vital dye acridine
orange (ao) shows the distribution of dying
cells in irradiated (D±F) and unirradiated (G±I)
discs. Staining with a mitosis-specific anti-
body against phospho-histone H3 shows the
pattern of mitotic cells in irradiated (J±L) and
unirradiated (M±O) discs.
in the posterior of the wing disc, radiation-induced apo- shown). This result is consistent with the normal levels
of mitosis and apoptosis in unirradiated wing discs ex-ptosis is greatly reduced in that region (Figures 4E and
4F). This reduction is not due to minor differences in the pressing dominant-negative Dmp53 (Figures 4H, 4I, 4N,
and 4O). Similarly, widespread expression of dominant-age or handling of the discs since a robust radiation-
induced apoptosis is observed in the anterior portion of negative Dmp53 using a tubulin-GAL4 driver does not
generate any obvious adult phenotypes (not shown).the disc where dominant-negative p53 is not expressed.
Together, these results indicate that Dmp53 is required These results suggest that, like Hp53, Dmp53 is required
in vivo to respond to certain cellular stresses, but mayfor radiation-induced apoptosis in the wing, but not for
the normal levels of cell death that occur in the absence not be essential for normal development. This role is
unlike that of the mammalian homolog p63, which isof DNA-damaging agents.
We also examined the effect of dominant-negative required for limb development in both humans and mice
(Celli et al., 1999; Mills et al., 1999; Yang et al., 1999).Dmp53 on radiation-induced arrest of cell cycle progres-
sion. In mammals, p53 is required for radiation-induced We also examined the consequence of increased lev-
els of wild-type Dmp53. Animals expressing wild-typeG1/S arrest and has variable effects on radiation-induced
G2/M arrest. The Drosophila wing exhibits a G2/M DNA Dmp53 using either the hsp70 or actin5C promoters did
not survive to adulthood. Expression of Dmp53 usingdamage checkpoint (Brodsky et al., 2000) that is depen-
dent on genes such as mei-41 (a homolog of the human an eye-specific glass-dependent promoter leads to in-
creased apoptosis in the eye imaginal disc and resultedATM checkpoint gene; Hari et al., 1995) and grapes (a
homolog of the yeast chk1 gene; Fogarty et al., 1997). in a rough, small eye phenotype (not shown); similar
expression of Dmp53(259H) had no effect on eye mor-Irradiation of wild-type wing discs blocks entry into mito-
sis (Figures 4J and 4M); this block is not affected by phology. Unlike radiation-induced apoptosis (Hay et al.,
1994), apoptosis due to overexpression of Dmp53 wasexpression of dominant-negative Dmp53 (Figures 4K, 4L,
4N, and 4O). Thus, although Dmp53 is required for radia- not suppressed by coexpression of the viral caspase-
inhibitor p35; this observation suggests that overexpres-tion-induced apoptosis, our data do not support a role for
this protein during the G2/M checkpoint in the wing. sion of Dmp53 is sufficient to induce apoptosis, but
that the response is either qualitatively or quantitativelyIn animals expressing dominant-negative Dmp53 un-
der the control of engrailed-GAL4, the size and pat- different from the apoptotic response to DNA damage.
Since the action of at least one Drosophila caspase isterning of the adult wing is not noticeably altered (not
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Figure 5. Identification of a Radiation-Responsive Enhancer at the reaper Locus
(A) A schematic of the upstream region of the Drosophila rpr gene. The regions tested are depicted as bars. Fragments continuous with the
BsmI site include the native reaper promoter while all others were tested with the hsp70 minimal promoter. Each fragment was fused to a
lacZ reporter gene and tested for radiation induction in the embryo. Names reflect the fragment size in kilobases (kb) or base pairs (see
Experimental Procedures for a description of each transgene). Regions retaining radiation-responsive enhancer activity are indicated as filled
bars and unresponsive regions are indicated as open bars. The arrow indicates the direction of rpr transcription.
(B) A schematic of the radiation inducible 150 bp enhancer is shown. The 20 bp potential p53 binding site is represented as four arrows, each
of which depicts the location and orientation of the 5 bp binding site for a p53 monomer. Since the sequence is p53 responsive in yeast
(Figure 5C), the element is referred to as p53RE. The p53RE is aligned to the human p53 binding site consensus.
(C) Yeast one-hybrid assays were used to test whether Drosophila p53 could direct transcription from the p53RE sequence. Four independent
transformants (three shown) of pGAD-Dmp53, pGAD-DmpP53(259H), or pGAD (empty vector) into yeast strains containing the reporter plasmid
pLacZi-p53RE were stained for b-galactosidase activity. GAL4-Dmp53 fusions activated transcription from the pLacZi-p53RE reporter while
the GAL4-Dmp53(259H) mutant was indistinguishable from the empty vector.
insensitive to p35 expression (Meier et al., 2000), overex- that cis-regulatory sequences responsible for damage-
induced transcription of rpr can be isolated from otherspression of Dmp53 may activate apoptosis though a
that respond to developmental cues.p35-resistant caspase.
The rpr Radiation Responsive Enhancer ContainsLocalization of a Radiation Responsive Enhancer
a Drosophila p53 Response Elementat the reaper Locus
Within the 150 bp enhancer, we identified a 20 bp se-The genomic region containing rpr, grim, and hid is
quence that strongly resembles the consensus for hu-
required for all cell death in Drosophila embryos, includ-
man p53 DNA-binding sites (el-Deiry et al., 1992). We
ing radiation-induced apoptosis (White et al., 1994). rpr
refer to this 20 bp sequence as the p53 response ele-
is transcriptionally induced in embryos following irradia- ment (p53RE) to reflect its response to Dmp53 in yeast
tion, and an 11 kb sequence upstream of the rpr start (see below). Like those found upstream of the human
codon is sufficient to confer radiation responsiveness target genes mdm-2 (Wu et al., 1993) and p21/WAF1
on a lacZ reporter transgene (Nordstrom et al., 1996). To (el-Deiry et al., 1993), this putative p53 binding site up-
identify the minimal radiation-responsive cis-elements stream of rpr contains two tandemly arrayed 10mers,
upstream of rpr, we tested the ability of smaller frag- each of which matches the consensus motif at nine of
ments of this 11 kb regulatory region to activate lacZ ten positions (Figure 5B). The two mismatches (shown
transcription (Figure 5A). Each transgenic strain was in lower case) occur at the outer positions of the 20 bp
tested for radiation-induced expression of b-galactosi- element; the invariant core nucleotides of each 10mer
dase as described previously (Nordstrom et al., 1996). motif match the consensus perfectly.
From this series, multiple constructs containing se- We tested whether Drosophila p53 interacts with the
quences z5 kb upstream of the rpr start codon showed p53RE by conducting yeast one-hybrid assays similar
a robust radiation response (e.g., 2kb-lacZ in Figure 5A, to those in Figure 2. For these studies, a reporter plasmid
Figure 6). These experiments identify a discrete 150 bp containing the p53RE upstream of the b-galactosidase
enhancer (Figures 5A and 5B) that responds to radiation gene was integrated into the yeast genome to produce
as strongly as the larger enhancer fragments tested. the p53RE bait strain. Next, this p53RE bait strain was
Since this enhancer retains radiation-responsiveness transformed with test plasmids expressing either wild-
but does not recapitulate the developmental patterns type Dmp53 or Dmp53(259H) fused to the GAL4 activa-
of rpr expression seen with larger enhancer fragments tion domain. These strains were assayed for b-galactosi-
dase activity (Figure 5C). Reporter expression in strains(see Nordstrom et al., 1996), the results also indicate
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Figure 6. Reporter Transgenes Containing
the p53RE Are Radiation-Inducible
Transgenic lines were tested for radiation re-
sponsiveness as described in Experimental
Procedures. At least three independent trans-
genic lines were tested for each reporter
construct (see Figure 5 for description of
constructs). Representative stainings with
antibodies against b-galactosidase are shown.
Similar results were obtained with b-galac-
tosidase activity assays (not shown). Note:
the staining in untreated embryos highlights
the clypeolabrum and precursors of the fore-
gut and hindgut; this is a common feature
among all responsive lines. Unresponsive
strains and control transgenes showed no in-
duction or reduced b-galactosidase activity
when irradiated (see Nordstrom et al., 1996).
with Dmp53(259H) or the empty vector control (express- suppressed by deletions for the genomic region con-
taining rpr, hid, and grim and is preceded by a dramaticing the Gal4 activation domain alone) are indistinguish-
able from each other. Compared to these controls, each induction of rpr expression, similar to that seen in irradi-
ated embryos (White et al., 1994; Nordstrom et al., 1996).of the four independent transformants carrying the wild-
type Dmp53 plasmid showed a substantial increase in We tested whether transcriptional activation mediated
by p53RE represents a specific response to radiationb-galactosidase levels. Based on these results, we con-
clude that the 150 bp radiation-responsive enhancer damage or a common integration point for multiple path-
ways that lead to excess apoptosis. We examined b-gal-upstream of rpr contains a 20 bp binding site for Dmp53.
actosidase expression in wild-type and crb embryos
carrying either the p53RE-lacZ or the 2kb-lacZ reporterThe p53 Response Element Is Sufficient
constructs (Figure 7). In stage 12/13 wild-type embryos,for Radiation-Induced Transcription
expression of the 2kb-lacZ transgene is normally con-We next tested whether the p53RE is sufficient to confer
fined to the developing gut but, in similarly aged crbradiation-responsive transcriptional activation upon a
embryos, expression is induced throughout the epider-lacZ reporter construct in vivo. A transgene containing
mis. In contrast, the p53RE-lacZ transgene exhibits onlyfour copies of the p53RE and the minimal hsp70 pro-
basal expression in either wild-type or crb embryos (Fig-moter showed negligible expression in untreated em-
ure 7). Thus, despite widespread apoptosis in crb em-bryos but was substantially induced following irradiation
bryos, there is no induction of reporter expression from(Figure 6). Therefore, the 20 bp Dmp53 binding site from
the p53RE. These results indicate that the p53RE specifi-the rpr locus is sufficient to mediate a transcriptional
cally responds to radiation damage, not generally to allresponse to radiation and may define a minimal radiation
proapoptotic signals. They also indicate that irradiationresponsive sequence. When analyzed in parallel to the
and disrupted development may activate rpr expression150-lacZ reporter, the p53RE-lacZ reporter exhibits less
through distinct pathways.robust and less uniform b-galactosidase activity follow-
ing irradiation (not shown). Reduced activity is often
observed when DNA elements are tested in isolation Concluding Remarks
from the normal flanking sequences and, in this in- To help understand the function of p53 in animal cells,
stance, may reflect the influence of other factors that we have characterized a p53 homolog in Drosophila. The
interact with the 150 bp enhancer sequence. overall structure of human and fly proteins is conserved,
each containing an N-terminal acidic domain, a DNA-
binding domain, and an oligomerization domain. MostThe p53 Response Element in the reaper Locus
Is Unresponsive to a Signal that Induces Excess conserved is the DNA-binding domain, showing 24%
identity over 198 amino acids. Within this domain, allApoptosis during Abnormal Development
Disruptions of development are often associated with six of the major mutation hotspots found in human tu-
mors are conserved in the fly protein. Protein function isexcess apoptosis (reviewed in Abrams, 1996). For exam-
ple, in a crumbs (crb) mutant background, abnormal also conserved; in yeast and in cultured cells, Drosophila
p53 activates transcription of reporter genes containingepidermal development in the embryo leads to wide-
spread apoptosis (Tepass and Knust, 1990; Tepass et canonical human p53 DNA-binding sites. A complete
assessment of the in vivo function of p53 will requireal., 1990; Abrams et al., 1993). This apoptosis is fully
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Figure 7. The p53RE Is Unresponsive to Sig-
nals that Promote Excess Apoptosis during
Abnormal Development
The indicated transgenic lines (described in
Figure 5) were stained with antibodies against
b-galactosidase in wild-type or crb embryos.
Wild-type staining patterns of comparably
staged embyros (stage 12/13) are also
shown. Note that widespread induction of the
2kb-lacZ reporter occurs throughout the epi-
dermis in crb embryos but no induction of
the p53RE-lacZ transgene is observed.
59 oligonucleotide contained the sequence GGATCCAAAATG to in-the isolation of null mutations at this locus. However,
troduce a BamHI site (underlined) and a Drosophila translation startby using dominant-negative variants, we have estab-
site (CAAAATG) before the Dmp53 sequence beginning at aminolished a role for Dmp53 in DNA damage-induced apopto-
acids 2, 84, or 282. Point mutations were introduced into the open
sis. The data in the accompanying paper by Ollmann et reading frame by PCR and were reamplified with flanking BamHI
al. (2000 [this issue of Cell]) also indicate that Drosophila and XhoI sites. Dmp53 derivatives were introduced into the yeast
p53 is a functional homolog of mammalian p53. The two-hybrid vectors pGAD-C1 and pGBDU-C1 (James et al., 1996)
at the BamHI and SalI sites. Dmp53 derivatives were introducedconservation of p53 structure and in vivo function sug-
into the pGUS vector at the BglII and XhoI sites. pGUS is a derivativegests that genetic analysis of p53 in Drosophila may
of the pGMR and pUAS vectors containing binding sites for theprovide clues to human p53 function.
GAL4 and Glass transcription factors (M. H. B., unpublished). All
In this study, we identified rpr as one potential effector PCR-derived constructs were confirmed by sequencing.
of the proapoptotic function of Dmp53. We show that Reporter transgenes with fragments of the rpr upstream regula-
a radiation-responsive enhancer from rpr contains a tory region were constructed with either the rpr (pR series) or mini-
mal Hsp70 (pH series) promoters. pR-7kb-LacZ, pR-5kb-LacZ, andDmp53 responsive element and this element is sufficient
pR-2kb-LacZ were prepared by digestion of Rpr-11-lacZ by Bgl2,to mediate radiation-induced transactivation in the em-
StuI, and EagI respectively, followed by EcoRI digests to release thebryo. One likely mechanism for RPR function is to block
distal DNA fragments, and blunting by T4 DNA polymerase beforecaspase repression through a direct association with
ligation. pH-3.5kb-LacZ was prepared by insertion of the 3.5 kb
the caspase inhibitor DIAP1 (Wang et al., 1999; Goyal, XbaI-XbaI fragment from Rpr-11-lacZ into the SpeI site of pCHAB
2000). Together, the results suggest a testable model in the inverted orientation relative to the promoter. pH-1.5-LacZ was
for DNA damage±induced apoptosis in the Drosophila created by T4 blunting and ligation after release of the NotI-StuI
fragment from pH-3.5kb-LacZ. pH-2kb-LacZ was created by T4embryo: damage-associated signals operate through
blunting and ligation after release of the BamHI-StuI fragment fromDrosophila p53 to induce rpr transcription and the newly
pH-3.5kb-LacZ. Truncations of pH-2-LacZ were prepared by PCRsynthesized RPR protein binds IAPs and in this way
using the primers as indicated below where italics correspond toincreases caspase activity. Such a model suggests the
synthetic restriction sites. pH-p53RE-LacZ was prepared by liga-
possibility that mammalian p53 targets may include IAP tion of the Eco-p53RE(2x)-Mun double-stranded oligonucleotide
binding proteins. into the EcoR1 site of pCHAB and confirmed by sequencing to
The model proposed above describes only one contain two head-to-head copies. The Eco-p53RE(2x)-Mun oligonu-
cleotide was created by annealing together the primers indicatedbranch of the regulatory network controlling apoptosis
below. pLacZi-p53RE and pHisi1-p53RE were prepared by ligatingfollowing irradiation. For example, rpr-induced apopto-
the Eco-p53RE(2X)-Mun double stranded oligonucleotide into thesis is partially suppressed by mutations in Dark, an Apaf-
EcoRI sites of the ClonTech vectors pLacZi and pHisi-1, respectively.1/Ced4 homolog (Kanuka et al., 1999; Rodriguez et al.,
Oligos used to prepare inserts for indicated plasmids were as follows:
1999; Zhou et al., 1999), indicating that other regulators pH-400-LacZ: 59-CTAGAATTCGGTACCCGCCC-39, 59-GCGGATCC
of caspase activity may also influence rpr-dependent GGATAGAGGAAGGAGG-39; pH-800a-LacZ: 59-CTAGAATTCGGTA
apoptosis. Furthermore, given the many transcriptional CCCGCCC-39, 59-GCGGATCCGAGCACTACGGAT-39; pH-1.2kb-LacZ:
59-CTAGAATTCGGTACCCGCCC-39, 59-CGGGATCCGGAGAACTCAtargets of mammalian p53 (Ko and Prives, 1996; Yu et
CCGG-39; pH-800b-LacZ: 59-GAGGTCGACTCTAGAGGATCC-39,al., 1999), proapoptotic genes other than rpr are likely
59-GGAATTCACCGCCGAGGAGC-39; pH-500-LacZ: 59-GAGGTCGinduced by activated Drosophila p53. In many mamma-
ACTCTAGAGGATCC-39, 59-GGAATTCTAAGAGGTGTTGGCT-39; pH-lian cells, Bax, Bcl2, and Apaf-1 play a central role in 150-LacZ: 59-GAGGTCGACTCTAGAGGATCC-39, 59-GGAATTCCG
the regulation of apoptosis following DNA damage (el- TCCGCTCGACT-39; Eco-p53RE(2x)-Mun: 59-AATTCGACTTGTTC
Deiry, 1998). Thus, animal cells are likely to use both AAACATGTCAGTCGACTTGTTCAAACATGTCAGC-39, 39-GCTGAA
IAP and Apaf-1 family members to regulate caspase CAAGTTTGTACAGTCAGCTGAACAAGTTTGTACAGTCGTTAA-59.
activity during DNA damage±induced apoptosis. In fu-
ture studies, the identification and characterization of
Yeast One- and Two-Hybrid Analysis
additional Drosophila p53 targets will help better define To test interaction with a previously described Hp53 DNA-binding
the specific roles of individual targets and how they site, pGAD-Dmp53 plasmids were transformed into a derivative of
function in different developmental contexts. the yeast strain pJ69-4a (James et al., 1996) containing either the
reporter plasmid p53BLUE or the negative control plasmid pLacZi
(Luo et al., 1996) stably recombined into the URA3 gene. To testExperimental Procedures
transcriptional activation, pGBDU-Dmp53 plasmids were trans-
formed into pJ69-4a. To test oligomerization, pGAD-Dmp53 andPlasmid Constructions
pGBDU-p53 plasmids were cotransformed into pJ69-4a. b-galac-PCR amplification was used to introduce a 59 BamHI site and a 39
XhoI site flanking all or part of the Dmp53 open reading frame. Each tosidase expression was assayed by streaking on media containing
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